Overview

A Pilot Study on the Onset of Action of KTP, 20% in the Treatment of Acute Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee

Status:
Completed

Trial end date:
2007-08-01

Target enrollment:

Participant gender:

Summary

Open-label study to be conducted at 2 US investigational sites in subjects who have acute tendonitis or bursitis of the shoulder, elbow, or knee. Eligible subjects receive treatment with the KTP, applied once daily at the same application site for 3 consecutive days.

Phase:

Phase 2

Details

Lead Sponsor:

APR Applied Pharma Research s.a.
Endo Pharmaceuticals

Treatments:

Ketoprofen